These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5488064)

  • 21. [External use of cytostatics in psoriasis].
    Datskovskiĭ BM; Masetkin IP; Osnovina NG
    Vestn Dermatol Venerol; 1975 Sep; (9):70-3. PubMed ID: 1231367
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 24. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival of mice bearing a transplanted syngeneic lymphoma following treatment with cyclophosphamide, 5-fluorouracil, or 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Bruce WR; Valeriote FA; Meeker BE
    J Natl Cancer Inst; 1967 Aug; 39(2):257-66. PubMed ID: 18623943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line.
    Frondoza CG; Trivedi SM; Humphrey RL
    Cancer Treat Rep; 1982 Jul; 66(7):1535-44. PubMed ID: 7093969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A TRANSPLANTABLE PLASMA CELL TUMOUR IN THE STUDY OF CARCINOSTATIC AGENTS.
    ROSENOER VM; WHISSON ME
    Biochem Pharmacol; 1964 Apr; 13():589-602. PubMed ID: 14191865
    [No Abstract]   [Full Text] [Related]  

  • 28. Amyloidosis in mice bearing a transplantable plasma cell tumour.
    Lehner T; Rosenoer VM; Smith J
    J Pathol Bacteriol; 1967 Jul; 94(1):41-53. PubMed ID: 4167847
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some serum protein nitrogen mustard complexes with high chemotherapeutic selectivity.
    Wade R; Whisson ME; Szerkerke M
    Nature; 1967 Sep; 215(5107):1303-4. PubMed ID: 6052739
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of intraperitoneal administration of mineral oil in BALB-c mice: morphological patterns and blood changes].
    Invernizzi F; Galetti G; Fantini F; Mignone V
    Reumatismo; 1968; 20(2):136-9. PubMed ID: 5748162
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influencing of symptoms in plasmacytoma through chemotherapy].
    Gerhartz H; Keller M
    Verh Dtsch Ges Inn Med; 1969; 75():521-4. PubMed ID: 5400192
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
    Schabel FM
    Cancer Res; 1969 Dec; 29(12):2384-9. PubMed ID: 5369685
    [No Abstract]   [Full Text] [Related]  

  • 35. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biology of large solid tumours regressing with nitrogen mustard treatment: a study of the mouse plasma cell tumour Adj-pc-5 and the Walker carcinosarcoma 256.
    Goldacre RJ; Whisson ME
    Br J Cancer; 1966 Dec; 20(4):801-12. PubMed ID: 5964610
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of DNA repair inhibitors on e response of tumors treated with x-ray and alkylating agents.
    Gaudin D; Yielding KL; Stabler A; Brown J
    Proc Soc Exp Biol Med; 1971 May; 137(1):202-6. PubMed ID: 5581662
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the content and composition of gangliosides of tumors as affected by chemotherapeutic agents].
    Kozlov AM; Novikov AM; Bassalyk LS; Sof'ina ZP
    Eksp Onkol; 1984; 6(5):62-6. PubMed ID: 6510346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
    Clifford P; Singh S; Stjernswärd J; Klein G
    Cancer Res; 1967 Dec; 27(12):2578-615. PubMed ID: 6082297
    [No Abstract]   [Full Text] [Related]  

  • 40. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.